GCC Regulatory Affairs Pharma Summit’s Post

Great news for Saudi Healthcare! AVALON Pharma, a leading local player, has partnered with Al-Dawaa Medical Services Co. (DMSCO) to manufacture essential medications. This collaboration aims to create a secure and affordable #supplychain for Saudi patients. By producing drugs locally, the agreement reduces dependence on external sources and minimizes medication shortages. Additionally, Avalon Pharma and DMSCO prioritize offering high-quality medications at competitive prices, making them more accessible for citizens. This initiative not only strengthens Saudi Arabia's healthcare infrastructure but also contributes to the nation's #economicdevelopment through job creation. Avalon Pharma sees this as a crucial step towards a more secure and prosperous healthcare system for Saudi Arabia. What can other countries do to encourage local drug manufacturing? Let's discuss! #SaudiArabia #AvalonPharma #DMSCO #SaudiVision2030 #PatientAccess #Localization #LocalManufacturing #AffordableDrugs #CompetitivePricing #HealthcareInfrastructure #SaudiArabia #GulfCountruies #MENA #RASLifeScienceSolutions #MarketIntelligence #MarketResearch #CompetitiveIntelligence #StrategySupport #PortfolioOptimization #MarketExpansion #PartnerIdentification Detailed News: https://lnkd.in/dHk2jYxW Follow our page for more industry updates: https://lnkd.in/de5zNWmK

How the MEA development will affect the Marketing authorization & the Reimbursement timelines ? ✋ In 2024, regional developments will impact marketing authorization processes and reimbursement timelines, underlining the importance of adaptability for executives navigating this landscape. Turkey introduces legislation allowing post-registration drug analyses, streamlining authorization timelines and simplifying market entry. In the UAE, firms must now engage with the federal government for clarity on revised marketing authorization processes, ensuring smooth operations. Algeria sees the Ministry of Finance allocating funds to the Central Hospitals Pharmacy to clear debts with public hospitals, reducing reimbursement timelines. Conversely, Kuwait faces potential delays in FY 2024/25 budget approvals, likely extending reimbursement timelines. Economic challenges in Egypt suggest no improvement in reimbursement timelines for 2024. Nigeria signals a possible shift towards pooled procurement and localization to manage rising drug prices. Saudi Arabia is set to transform its pharmaceutical procurement process, with NUPCO leading direct procurement from manufacturers and aiming for an increased presence in the private sector. South Africa's DapLab Meds will continue being pivotal in driving pharmaceutical demand in public healthcare, highlighting the value of partnerships with public stakeholders in 2024.... 👨⚖️ #MEA #pharmaceuticals #Market access # reimbursement # AMM #pch #registration # 2024 regulatory

The collaboration between AVALON Pharma and Al-Dawaa Medical Services Co. (DMSCO) to locally manufacture essential medications is a game-changer. By ensuring a secure and affordable #supplychain, this partnership will greatly reduce dependence on external sources and help prevent medication shortages. Not only does this initiative promise high-quality medications at competitive prices, but it also significantly strengthens our healthcare infrastructure and contributes to #economicdevelopment through job creation. It's a crucial step toward a more resilient and prosperous healthcare system in Saudi Arabia. I'm curious, what steps can other countries take to boost local drug manufacturing? Let's discuss! #SaudiArabia #AvalonPharma #DMSCO #SaudiVision2030 #PatientAccess #Localization #LocalManufacturing #AffordableDrugs #CompetitivePricing #HealthcareInfrastructure #GulfCountries #MENA #RASLifeScienceSolutions #MarketIntelligence #MarketResearch #CompetitiveIntelligence #StrategySupport #PortfolioOptimization #MarketExpansion #PartnerIdentification

Are you need to know how pharmaceutical products moved to patients in Saudi Arabia? The value chain for #pharmaceutical products in #Saudi_Arabia involves several key stages: 1) #Research_and_Development (#R&D): in last decade Saudi Arabia shows an increasing focus on establishing a local R&D infrastructure within the country. 2) #Regulatory Approval: The Saudi Food and Drug Authority (#SFDA) is responsible for ensuring that all pharmaceuticals meet the necessary standards for safety, efficacy, and quality before they are approved for market entry. 3) #Manufacturing: There’s a strategic push towards local manufacturing of both generic and branded drugs to support economic diversification and reduce import dependency. 4) #Distribution: Pharmaceuticals are distributed through hospital pharmacies, and retail pharmacies, ensuring nationwide availability. 5) #Sales_and_Marketing: Companies engage in activities to promote their products to healthcare providers and consumers, including doctor detailing and media advertising which are controlled by SFDA Guidelines and Supervision. 6) #Retail: Pharmacies serve as the final point of sale (in private sector), with ongoing efforts to optimize the supply chain for better drug availability. 7) #Governmental Facilities and Services: #Ministry_of_Health (MoH): The MoH oversees healthcare and health policy in Saudi Arabia. It formulates strategies for public health, manages health infrastructure, and provides integrated healthcare services across all regions. Healthcare in government medical facilities is provided free of charge to citizens based on a new health strategy. #Primary_Care_Centers: These centers offer essential healthcare services to citizens and residents. #Medical_Cities and #Specialized_Hospitals: These facilities provide specialized care, including university and military hospitals. #Hajj and #Umrah Periods: During these religious pilgrimages, healthcare services are extended to millions of visitors. 8)The National Unified Procurement Company (#NUPCO) plays a crucial role in the healthcare value chain in Saudi Arabia. Established in 2009 and fully owned by the #Public_Investment_Fund #PIF, NUPCO is the leading entity in procurement, logistics, and supply chain management for pharmaceuticals, medical devices, and supplies for governmental hospitals in the Kingdom. The pharmaceutical market in Saudi Arabia is expanding due to improvements in healthcare, strategic partnerships, and the introduction of new medications, along with government initiatives to boost local manufacturing capabilities. I tried to make the story as simple as possible. Did I miss anything, or is there anything that needs to be amended to better reflect the real situation?

🌟 [𝐀𝐮𝐝𝐚𝐜𝐞’𝐬 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬] 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐌𝐚𝐥𝐚𝐲𝐬𝐢𝐚’𝐬 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 🌟 🌱 In the heart of Southeast Asia, Malaysia's pharmaceutical market is emerging as a beacon of growth and opportunity. With a projected revenue of US$1,618.00m in 2024, it's clear that Malaysia is on the brink of a healthcare revolution. At Audace, we've been closely monitoring this vibrant market, and here's what we've found: 🛍️ 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐏𝐫𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞𝐬 Malaysian consumers are becoming increasingly health-conscious, leading to a higher demand for pharmaceutical products. Additionally, the aging population in Malaysia has resulted in a higher demand for medication for chronic diseases. 📈 𝐓𝐫𝐞𝐧𝐝𝐬 𝐈𝐧 𝐓𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 One trend in the Malaysian pharmaceutical market is the growth of generic drugs. The Malaysian government has been promoting the use of generic drugs to reduce healthcare costs, leading to an increase in demand for these products. Another trend is the increasing use of e-commerce for pharmaceutical purchases, allowing for greater convenience and accessibility for consumers. 💡 For our esteemed clients sourcing pharmaceutical products from Vietnam, Audace offers unparalleled expertise and support in navigating the flourishing Malaysian market. 🤝 Connect with Audace today to explore how we can support your business in capturing the vast opportunities within Malaysia’s evolving pharmaceutical market. Statistics Source: Statista Market Insights #AudacePharma #AudaceVietnam #Malaysia #MalaysiaPharmaceutical #PharmaSolutions #PharmaServices #VietnamPharmaceuticalManufacture ---------------------------- 📌 𝐀𝐔𝐃𝐀𝐂𝐄 𝐏𝐇𝐀𝐑𝐌𝐀 - 𝐓𝐡𝐞 𝟏𝐬𝐭 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐞𝐫 𝐀𝐠𝐞𝐧𝐜𝐲 𝐈𝐧 𝐕𝐢𝐞𝐭𝐧𝐚𝐦  📬 Address: 149 Giang Vo Street - Cat Linh Ward - Dong Da District - Hanoi City 📞 Hotline: (+84) 961 626 691  📍 Website: audacepharma.com 📎 Linkedin: https://lnkd.in/gipmJp2V 📲 X: https://lnkd.in/gGGJ6cDi 📩 Email: audacepharma@gmail.com

𝐌𝐈𝐃𝐃𝐋𝐄 𝐄𝐀𝐒𝐓 𝐋𝐀𝐓𝐄𝐒𝐓: 🇸🇦 The Saudi Food & Drug Authority (SFDA) has released new Economic Evaluation Studies (EES) Guidelines to support manufacturers and marketing authorisation holders in evaluating the cost-effectiveness of healthcare interventions. These studies will help the SFDA assess the value of new treatments against existing healthcare practices in Saudi Arabia, promoting more informed decision-making in the healthcare sector. Analyst Manahill Baig has summarised how these guidelines reflect Saudi Arabia’s commitment to advancing its healthcare industry and positioning the country as an emerging leader in the global biopharma market in our latest article: ➡️ 🔗 https://lnkd.in/eM6cKGaH #middleeastnews #marketaccess #healthcare #pharmaceuticals #emergingmarkets #sfda

What a successful conclusion to the GCC Regulatory Affairs Pharma Summit 2024! We're thrilled to wrap up an enlightening event filled with dynamic discussions and invaluable insights from regulatory authorities across the region. A special shoutout to our esteemed panelists who led the in-depth Roundtable discussions at the end of Day 2, today: ·      Dr. Eman Hussien, Regulatory Administration Director, Central Administration of Pharmaceutical Affairs, Egyptian Drug Authority (EDA) ·      Dr. Rana Musa al-ali "Malkawi", Drug Directorate Director, Regulatory Affairs Consultant, Jordan Food and Drug Administration المؤسسه العامه للغذاء والدواء الأردنيه (JFDA) ·      Dr. Meriem Sellam, Dr. saida F. , Dr. lafri oumhani and Dr. Naoual Assam from the Agence Nationale des Produits Pharmaceutiques ·      Dr. Mohammed Al-Rufaye, Prime Pharmacist, Chairman of Re/Registration Committee, Iraq Ministry of Health A big thank you to all participants, sponsors, and supporters for making this summit a resounding success! Stay tuned for more updates and future collaborations. Now it is time for the #GCCPharmacovigilanceTraining and the #MedicalTenderandBusinessTalk, that will begin tomorrow so get geared up for more informative updates and highly valuable insights! #GCCRegulatoryAffairsPharmaSummit #RegulatoryAffairs #PharmaceuticalIndustry #Collaboration #HealthcareExcellence #GCC #JFDA #EDA #Iraq #Algeria

Day 4 🔍 𝐇𝐚𝐫𝐦𝐨𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬: 𝐀 𝐍𝐞𝐜𝐞𝐬𝐬𝐢𝐭𝐲 𝐟𝐨𝐫 𝐀𝐟𝐫𝐢𝐜𝐚 African Medicines Agency Treaty Alliance (AMATA) , through the African Medicines Agency (AMA), aims to unify pharmaceutical regulations across the continent, ensuring better patient safety and facilitating access to quality medicines. ⚖️💉 𝐖𝐡𝐲 𝐢𝐬 𝐢𝐭 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭? - 𝐅𝐞𝐰𝐞𝐫 𝐭𝐫𝐚𝐝𝐞 𝐛𝐚𝐫𝐫𝐢𝐞𝐫𝐬: Harmonizing regulations reduces obstacles to the trade of pharmaceutical products between African countries, thus facilitating the rapid distribution of essential medicines. 📦🌍 - 𝐅𝐚𝐬𝐭𝐞𝐫 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐞𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬: A unified regulatory framework accelerates the approval and availability of vital medicines, saving lives and improving public health. ⏱️💊 - 𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐢𝐧𝐠 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐜𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐜𝐞: By ensuring that all medicines meet the same high-quality standards, the AMA boosts patient trust in the available pharmaceutical products. 🛡️❤️ - 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐥𝐨𝐜𝐚𝐥 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫𝐬: Providing clear and uniform guidelines, the AMA supports local medicine manufacturers, stimulating local production and creating jobs. 🏭💼 - 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬: Harmonized regulations facilitate partnerships with international organizations, attracting investments and global expertise to the African healthcare sector. 🌐🤝 The AMA, a pillar for health in Africa, works towards a future where all Africans have access to safe and effective healthcare! 🌍💪 IPSF African Regional Office (IPSF AfRO) IPSF Eastern Mediterranean Regional Office (IPSF EMRO) #HealthAfrica #AMATA 💊🌍

In the 1970s, the pharmaceutical market in Egypt experienced significant growth, with local manufacturing facilities producing more products under license from foreign companies. Multinational companies also established branches in Egypt for local production. EGYDRUG's extensive branch network efficiently served this expansion. Importation of products protected by intellectual property patents was exclusively handled by EGYDRUG. Credit facilities were offered to pharmacies and hospitals for local production, with a 45-day payment period, while imported products required cash payment. Although supply was lower than demand and operational costs were low, EGYDRUG, being a state company, was not managed for profitability. The entry of the private sector into pharmaceutical distribution introduced competition, with new manufacturers like Amoun, EIPICO, Pharco, Ameryia, and October emerging to address shortages. This led to the emergence of new distributors, and EGYDRUG's market share declined. Increased competition resulted in improved service levels, discounts, and credit limits, and EGYDRUG was no longer the distributor of choice. #EGYDRUG #PharmaceuticalDistribution #Egypt #HealthcareIndustry #Nationalization

"Wishing you a very Happy Ugadi filled with joy, prosperity, and new beginnings! May this auspicious occasion bring you and your loved ones abundant blessings and success. Happy Ugadi!" #Ugadi #HinduNewYear #ChaitraMonth #SpringSeason #NewBeginnings #Yugadi #LordBrahma #FestivalOfCreation #IndianCulture #HinduTradition #SouthIndianFestival #nabl #cdsco #medicaldevices #medicaldevice #medicalequipments #environmentalmonitoring #cleanroomtechnology #cleanroom #cleanrooms #cleanroomvalidation #validation #bis #softwarearchitecture #softwarearchitect #infrastructuremanagement #pharmaceutical #pharmaceuticalindustry #pharmaceuticalcompanies #pharmaindustry #iso #environmentalmonitoring #airquality #airqualitymatters #ISO14644 #Sustainablescience #cleanair #cleanairmatters #cleanairforall #microbial #microbialmonitoring #MicrobialMonitoring #ScientificStandards #ResearchResponsibility #InnovationInResearch #EnvironmentalStewardship #RegulatoryCompliance #PrecisionScience #LaboratoryExcellence #HealthyEnvironments #QualityAssurance #ScientificIntegrity